This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring 2022 Digital
March 28–31, 2022
Delivered Digitally

Leah Lipsich
VP Strategic Program Direction at Regeneron Pharmaceuticals


Leah’s interest is in the development of products that help patients in the arenas of any unmet medical need.  Leah’s career has offered tremendous opportunity in areas of infectious disease, immunology and inflammation and general medicine. 

.Leah has had multiple positions in industry including roles at Ingene, Bristol Myers Squibb, Boehringer Ingelheim, Purdue Pharma, UCB, Elan Drug Technologies and Regeneron.  Initially, her focus was in research of biologicals, particularly therapeutic monoclonal antibodies in the treatment of cancer and infectious disease.  Leah has focused her career on product development and seeing important discoveries make it through the development pathway.  Throughout her career Leah has been presented with numerous opportunities to move drug candidates through to IND/CTA and ultimately NDA/BLA.  Leah has equivalent experience in both NCE and NBE development in varied dosage forms and has taken many products into development and ultimately to the marketplace.

Agenda Sessions

  • Pandemic therapeutics: treating COVID-19 and beyond


Speakers at this event